Evidence map›Paper›PMID 41709826›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Programmable Klebsiella pneumoniae Phage Tropism Enabled by Scalable Receptor-Binding Protein Mining and Modular Assembly.

Shisong Jing, Yiyao Song, Xianbiao Bi, Yuqin Song, Dawei Wei, Jiangqing Huang, Yuan Zeng, Gang Zhang, Rong Zhang, Chao Wang and 1 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. mBio · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shisong JingState Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Yiyao SongSchool of Clinical and Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Xianbiao BiState Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Yuqin SongState Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Dawei WeiState Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Jiangqing HuangState Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Yuan ZengState Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Gang ZhangState Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Rong ZhangDepartment of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Chao WangState Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Jie FengState Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.ORCID https://orcid.org/0000-0001-5172-6643

Funding

Chinese Academy of Sciences 079GJHZ2022033GCNational Key R&D Program of China 2024YFA0919400
6 · The paper itself

Abstract

Phage therapy is an attractive countermeasure to multidrug-resistant pathogens, but clinical deployment is limited by the narrow and poorly predictable host range of most phages. Public repositories now house tens of thousands of phage genomes, yet there is no systematic route for turning this sequence space into designer phages with defined receptor specificities. Here we present a scalable, data-driven framework that converts receptor-binding protein (RBP) diversity into a modular toolkit for programmable phage engineering. Using Klebsiella pneumoniae as a model, we mined 280 non-redundant Przondovirus RBP sequences and resolved them into >50 discrete clusters. Functional screening of the Prz_RBPs from 41 previously uncharacterized Przondovirus phages expanded the number of experimentally validated capsular locus (KL) targets from 14 to 32 in Przondovirus. Each cluster was primarily associated with a dominant KL type, enabling construction of a genotype-to-phenotype map that accurately predicts receptor tropism. The identification of conserved anchor motifs enabled combinatorial pairing of Prz_RBP1 and Prz_RBP2 as plug-and-play modules for programmable phage tropism. Supplying exogenous Prz_RBP2 variants that assemble with Prz_RBP1 further and predictably expands host range, providing broad and tunable coverage. This framework transforms raw genomic diversity into customizable antibacterial agents and offers a general blueprint for precision phage therapy.

Indexed as

BacteriophagesKlebsiella pneumoniaePhage TherapyViral TropismGenome, Viralantimicrobial resistancecapsular tropismprogrammable phagesreceptor‐binding proteins (RBP)synthetic biology

Identifiers

PMID41709826
PMCPMC13073335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.